Tag: Checkpoint inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Checkpoint inhibitor

BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - Yahoo Finance

Added to Collection on: 2025-09-13 11:31:47

Tags for this article:

Cancer immunotherapy
Lung cancer
Immune system
Clusters of differentiation
Orphan drugs
Checkpoint inhibitor
Pembrolizumab
PD-1 and PD-L1 inhibitors
Small-cell carcinoma
Vascular endothelial growth factor
Programmed cell death protein 1
PD-L1
BioNTech
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
Blocking Tumors: PD-L1 siRNA Boosts Immunotherapy - BIOENGINEER.ORG

Added to Collection on: 2025-09-13 11:52:23

Tags for this article:

RNA
Immune system
Molecular biology
Clusters of differentiation
Cancer immunotherapy
Programmed cell death protein 1
PD-L1
Small interfering RNA
Checkpoint inhibitor
RNA therapeutics
Immunotherapy
RNA interference

Click the tags to see associated articles and topics

View Article Details
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - sharewise

Added to Collection on: 2025-09-13 04:58:16

Tags for this article:

Cancer immunotherapy
Immune system
Lung cancer
Orphan drugs
Pfizer
Pembrolizumab
Checkpoint inhibitor
Bristol-Myers Squibb
PD-1 and PD-L1 inhibitors
BioNTech
Merck & Co.
Programmed cell death protein 1
Bristol-Myers Squibb Company
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
PDS Biotech reports 29.5 months of mOS in low PD-L1 expression patients with head and ...

Added to Collection on: 2025-09-18 13:07:08

Tags for this article:

Cancer immunotherapy
Antineoplastic drugs
Pembrolizumab
Otorhinolaryngology
Infectious causes of cancer
Head and neck cancer
Human papillomavirus infection
TIGIT
Checkpoint inhibitor

Click the tags to see associated articles and topics

View Article Details
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended ...

Added to Collection on: 2025-09-18 12:55:46

Tags for this article:

Cancer immunotherapy
Infectious causes of cancer
Virotherapy
Otorhinolaryngology
Pembrolizumab
Checkpoint inhibitor
Merck & Co.
Human papillomavirus infection
Forward-looking statement
Head and neck cancer
Immunotherapy

Click the tags to see associated articles and topics

View Article Details
ABCs of ADCs: A Guide to Evaluating the Next Generation - TD Securities

Added to Collection on: 2025-09-18 13:36:50

Tags for this article:

Antineoplastic drugs
Immunology
Biotechnology
Antibody-drug conjugate
Genetic engineering
Nucleic acids
ImmunoGen
Targeted therapy
Chemotherapy
Oligonucleotide
Checkpoint inhibitor
Monomethyl auristatin E

Click the tags to see associated articles and topics

View Article Details
Genmab swallows Merus in US$8bn deal - European Biotechnology Magazine

Added to Collection on: 2025-09-30 00:17:31

Tags for this article:

Cancer immunotherapy
Genmab
Epidermal growth factor receptor
Checkpoint inhibitor
Antineoplastic drugs
Nimotuzumab

Click the tags to see associated articles and topics

View Article Details
Peaks and valleys in bispecific antibody research - BioXconomy

Added to Collection on: 2025-10-01 15:56:19

Tags for this article:

Immune system
Immunology
Antineoplastic drugs
Cancer immunotherapy
Orphan drugs
Pembrolizumab
Monoclonal antibody therapy
Checkpoint inhibitor
Nivolumab
Ipilimumab
Antibody-drug conjugate
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Cartography secures $67M in pursuit of 'differentiated' cancer drugs - BioPharma Dive

Added to Collection on: 2025-10-02 17:37:33

Tags for this article:

Antineoplastic drugs
Cancer immunotherapy
Immune system
Cancer treatments
Checkpoint inhibitor
Monoclonal antibody therapy
Pembrolizumab
Colorectal cancer
Cancer
Immunocore
Chemotherapy
Amgen

Click the tags to see associated articles and topics

View Article Details
FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance ...

Added to Collection on: 2025-10-03 17:43:11

Tags for this article:

Orphan drugs
Lung cancer
Antineoplastic drugs
Atezolizumab
Small-cell carcinoma
Checkpoint inhibitor
Roche
Durvalumab
lurbinectedin
Oncology
Tiragolumab
TIGIT
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Book a Demo